ORMP:NASDAQ
Oramed Pharmaceuticals, Inc.
$4.81
arrow_upward
+0.42%(+0.020) 1D
$4.72
arrow_downward
-1.92% (-0.092)bedtimeAfter hours
Closed: Aug 21, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORMP...
Open
$4.81
High
$4.88
Low
$4.75
Mkt. cap
200.08M
Avg. vol.
180.38K
Volume
126.13K
P/E ratio
1.17
52-wk high
$5.19
52-wk low
$2.06
EPS
$4.13
Beta
1.22
Shares outstanding
41.60M
No. of employees
13
Open
$4.81
High
$4.88
Low
$4.75
Mkt. cap
200.08M
Avg. vol.
180.38K
Volume
126.13K
P/E ratio
1.17
52-wk high
$5.19
52-wk low
$2.06
EPS
$4.13
Beta
1.22
Shares outstanding
41.60M
No. of employees
13
News stories
From web sources and news partners
Profile
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
About Oramed Pharmaceuticals, Inc.
AI content may include mistakes. Learn more